Effects of lifestyle education program for type 2 diabetes patients in clinics: study design of a cluster randomized trial

Adachi, Misa; Yamaoka, Kazue; Watanabe, Mariko; Nishikawa, Masako; Hida, Eisuke; Kobayashi, Itsuro; Tango, Toshiro
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p742
Academic Journal
Background: The number of patients with type 2 diabetes is drastically increasing worldwide. It is a serious health problem in Japan as well. Lifestyle interventions can reduce progression from impaired glucose tolerance to type 2 diabetes, and glycemic control has been shown to improve postprandial plasma glucose levels. Moreover, several studies have suggested that continuous interventions (combined diet and exercise) can improve the plasma glucose level and reduce dosage of hypoglycemic agents. Although many interventional studies of lifestyle education for persons with diabetes in hospitals have been reported, only a few have been clinic-based studies employing an evidence-based lifestyle education program. This article describes the design of a cluster randomized controlled trial of the effectiveness of lifestyle education for patients with type 2 diabetes in clinics by registered dietitians. Methods/Design: In Japan, general practitioners generally have their own medical clinics to provide medical care for outpatients in the community, including those with type 2 diabetes. With the collaboration of such general practitioners, the study patients were enrolled in the present study. Twenty general practitioners were randomly allocated to each provide patients for entry into either an intervention group (10) or a control group (10). In total, 200 participants will be included in the study. The intervention group will receive intensive education on lifestyle improvement related to type 2 diabetes by registered dietitians in clinics. Lifestyle education will be conducted several times during the study period. The control group will receive information on dietary intake and standard advice on glycemic control by registered dietitians. The primary endpoint is the change from the baseline value of HbA1c at 6 months. Data on health behavior and related issues will be gathered continuously over a 6-month period. Discussion: This is the first study to evaluate lifestyle education in clinics by a cluster randomization trial in Japan. The proposed study will provide practical information about the usefulness of the intensive lifestyle improvement education program in primary care settings. The study was started in September 2007 and entry of subjects was completed in December 2010. Data on the effect evaluation will be available in 2011. Trial Registration: UMIN000004049.


Related Articles

  • Estudio Parto: postpartum diabetes prevention program for hispanic women with abnormal glucose tolerance in pregnancy: a randomised controlled trial - study protocol. Chasan-Taber, Lisa; Marcus, Bess H.; Rosal, Milagros C.; Tucker, Katherine L.; Hartman, Sheri J.; Pekow, Penelope; Braun, Barry; Moore Simas, Tiffany A.; Solomon, Caren G.; Manson, JoAnn E.; Markenson, Glenn // BMC Pregnancy & Childbirth;2014, Vol. 14 Issue 1, p1 

    Background: Diabetes and obesity have reached epidemic proportions in the U.S. with rates consistently higher among Hispanics as compared to non-Hispanic whites. Among Hispanic women diagnosed with gestational diabetes mellitus (GDM), 50% will go on to develop type 2 diabetes within 5 years of...

  • Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. Yan Shu; Sheardown, Steven A.; Brown, Chaline; Owen, Ryan P.; Shuzhong Zhang; Castro, Richard A.; Ianculescu, Alexandra G.; Lin Yue; Lo, Joan C.; Burchard, Esteban G.; Brett, Claire M.; Giacomini, Kathleen M. // Journal of Clinical Investigation;May2007, Vol. 117 Issue 5, p1422 

    Metformin is among the most widely prescribed drugs for the treatment of type 2 diabetes. Organic cation transporter 1 (OCT1) plays a role in the hepatic uptake of metformin, but its role in the therapeutic effects of the drug, which involve activation of AMP-activated protein kinase (AMPK), is...

  • Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects. Johansen, Odd Erik; Brustad, Ellen; Enger, Steve; Tveit, Arnljot // Cardiovascular Diabetology;2008, Vol. 7, p1 

    Background: The prevalence of atrial fibrillation (AF) is increasing world wide and amongst factors that aggravate the risk is diabetes mellitus (DM), also in epidemic development. However, although DM is a potentially modifiable risk factor for AF, few, if any, studies have explored the...

  • Demand up for better glucose self-monitoring devices.  // Healthcare Purchasing News;May2003, Vol. 27 Issue 5, p24 

    Reports on an increase in the demand for glucose self-monitoring devices in the U.S. Factors that contribute to the growing incidence of diabetes; Reason behind the adoption of devices; Revenue posted by self-monitoring devices market in 2002.

  • oral glucose tolerance test.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1639 

    A definition of the term "oral glucose tolerance test," which refers to a screening test for diabetes mellitus, is presented.

  • Pioglitazone for diabetes prevention. Elliott, William T. // Infectious Disease Alert;May2011 Clinical Bri, p1 

    The article reports on the discovery that pioglitazone reduces the risk of diabetes among patients with impaired glucose tolerance in an industry-sponsored study.

  • Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? Stern, Michael P.; Williams, Ken; Haffner, Steven M. // Annals of Internal Medicine;4/16/2002, Vol. 136 Issue 8, p575 

    Background: The standard method of identifying persons at high risk for type 2 diabetes mellitus involves detection of impaired glucose tolerance, which requires a costly and inconvenient 2-hour oral glucose tolerance test. Because clinical trials have indicated that diabetes is preventable by...

  • The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia. Tschritter, Otto; Stumvoll, Michael; Machicao, Fausto; Holzwarth, Martin; Weisser, Melanie; Maerker, Elke; Teigeler, Anna; Häring, Hans; Haring, Hans; Fritsche, Andreas; Häring, Hans // Diabetes;Sep2002, Vol. 51 Issue 9, p2854 

    Genetic factors play an important role in the pathogenesis of type 2 diabetes. The relevance to type 2 diabetes of the common polymorphism Glu23Lys in the potassium inward rectifier 6.2 (KIR6.2) gene is still controversial. The aim of this study was to assess whether this polymorphism influences...

  • Self testing for diabetes mellitus. Davies, Melanie; Alban-Davies, Huw; Cook, Christopher; Day, John // BMJ: British Medical Journal (International Edition);9/21/91, Vol. 303 Issue 6804, p696 

    Focuses on the self-testing for diabetes mellitus in Great Britain. Risk of macrovascular complications; Initiation of oral glucose tolerance tests; Number of cases identified.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics